Literature DB >> 27367789

Sticky Steroids: In Search of an Approved Treatment for Eosinophilic Esophagitis.

Nathalie Nguyen1, Glenn T Furuta, Calies Menard-Katcher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 27367789      PMCID： PMC5201455          DOI： 10.1097/MPG.0000000000001326

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN： 0277-2116            Impact factor:   2.839


× No keyword cloud information.
  16 in total

1.  Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial.

Authors:  Ranjan Dohil; Robert Newbury; Lyman Fox; John Bastian; Seema Aceves
Journal:  Gastroenterology       Date:  2010-05-07       Impact factor: 22.682

2.  Efficacy and safety of oral budesonide suspension in pediatric patients with eosinophilic esophagitis.

Authors:  Sandeep K Gupta; Joanne M Vitanza; Margaret H Collins
Journal:  Clin Gastroenterol Hepatol       Date:  2014-06-04       Impact factor: 11.382

3.  Oral viscous budesonide can be successfully delivered through a variety of vehicles to treat eosinophilic esophagitis in children.

Authors:  Juhee Lee; Michelle Shuker; Terri Brown-Whitehorn; Antonella Cianferoni; Laura Gober; Amanda Muir; Ritu Verma; Chris Liacouras; Jonathan M Spergel
Journal:  J Allergy Clin Immunol Pract       Date:  2016-03-26

4.  Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis.

Authors:  Alex Straumann; Sebastien Conus; Lukas Degen; Stephanie Felder; Mirjam Kummer; Hansjürg Engel; Christian Bussmann; Christoph Beglinger; Alain Schoepfer; Hans-Uwe Simon
Journal:  Gastroenterology       Date:  2010-08-01       Impact factor: 22.682

Review 5.  Eosinophilic esophagitis: updated consensus recommendations for children and adults.

Authors:  Chris A Liacouras; Glenn T Furuta; Ikuo Hirano; Dan Atkins; Stephen E Attwood; Peter A Bonis; A Wesley Burks; Mirna Chehade; Margaret H Collins; Evan S Dellon; Ranjan Dohil; Gary W Falk; Nirmala Gonsalves; Sandeep K Gupta; David A Katzka; Alfredo J Lucendo; Jonathan E Markowitz; Richard J Noel; Robert D Odze; Philip E Putnam; Joel E Richter; Yvonne Romero; Eduardo Ruchelli; Hugh A Sampson; Alain Schoepfer; Nicholas J Shaheen; Scott H Sicherer; Stuart Spechler; Jonathan M Spergel; Alex Straumann; Barry K Wershil; Marc E Rothenberg; Seema S Aceves
Journal:  J Allergy Clin Immunol       Date:  2011-04-07       Impact factor: 10.793

6.  Dissociation between symptoms and histological severity in pediatric eosinophilic esophagitis.

Authors:  Scott Pentiuk; Phillip E Putnam; Margaret H Collins; Marc E Rothenberg
Journal:  J Pediatr Gastroenterol Nutr       Date:  2009-02       Impact factor: 2.839

7.  Histological Response to Fluticasone Propionate in Patients With Eosinophilic Esophagitis Is Associated With Improved Functional Esophageal Mucosal Integrity.

Authors:  Bram D van Rhijn; Joanne Verheij; Marius A van den Bergh Weerman; Caroline Verseijden; René M J G J van den Wijngaard; Wouter J de Jonge; Andreas J P M Smout; Albert J Bredenoord
Journal:  Am J Gastroenterol       Date:  2015-08-25       Impact factor: 10.864

8.  Development and validation of a symptom-based activity index for adults with eosinophilic esophagitis.

Authors:  Alain M Schoepfer; Alex Straumann; Radoslaw Panczak; Michael Coslovsky; Claudia E Kuehni; Elisabeth Maurer; Nadine A Haas; Yvonne Romero; Ikuo Hirano; Jeffrey A Alexander; Nirmala Gonsalves; Glenn T Furuta; Evan S Dellon; John Leung; Margaret H Collins; Christian Bussmann; Peter Netzer; Sandeep K Gupta; Seema S Aceves; Mirna Chehade; Fouad J Moawad; Felicity T Enders; Kathleen J Yost; Tiffany H Taft; Emily Kern; Marcel Zwahlen; Ekaterina Safroneeva
Journal:  Gastroenterology       Date:  2014-08-23       Impact factor: 22.682

9.  A New Formulation of Oral Viscous Budesonide in Treating Paediatric Eosinophilic Oesophagitis: A Pilot Study.

Authors:  Salvatore Oliva; Danilo Rossetti; Paola Papoff; Antonio Tiberti; Paolo Rossi; Sara Isoldi; Jorge Amil Dias; Sandra Lucarelli; Salvatore Cucchiara
Journal:  J Pediatr Gastroenterol Nutr       Date:  2017-02       Impact factor: 2.839

10.  Cross-sector sponsorship of research in eosinophilic esophagitis: a collaborative model for rational drug development in rare diseases.

Authors:  Robert Fiorentino; Gumei Liu; Anne R Pariser; Andrew E Mulberg
Journal:  J Allergy Clin Immunol       Date:  2012-07-31       Impact factor: 10.793
View more
  1 in total

1.  Creating a multi-center rare disease consortium - the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR).

Authors:  Katherine Cheng; Sandeep K Gupta; Susanna Kantor; Jonathan T Kuhl; Seema S Aceves; Peter A Bonis; Kelley E Capocelli; Christina Carpenter; Mirna Chehade; Margaret H Collins; Evan S Dellon; Gary W Falk; Rashmi Gopal-Srivastava; Nirmala Gonsalves; Ikuo Hirano; Eileen C King; John Leung; Jeffrey P Krischer; Vincent A Mukkada; Alain Schoepfer; Jonathan M Spergel; Alex Straumann; Guang-Yu Yang; Glenn T Furuta; Marc E Rothenberg
Journal:  Transl Sci Rare Dis       Date:  2017-12-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.